IzotropicFRA:1R3 28 Market Cap is €10.24 Mil as of Jul. 02, 2026. GuruFocus rates FRA:1R3 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, Izotropic ranks worse than 77.52% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Izotropic's share price for the quarter that ended in Jan. 2026 was €0.1335. Izotropic's Shares Outstanding (EOP) for the quarter that ended in Jan. 2026 was 67.79 Mil. Therefore, Izotropic's market cap for the quarter that ended in Jan. 2026 was €9.05 Mil.
Izotropic's quarterly market cap
increased
from Jul. 2025 (€9.64 Mil) to Oct. 2025 (€17.46 Mil) but then
declined
from Oct. 2025 (€17.46 Mil) to Jan. 2026 (€9.05 Mil).
Izotropic's annual market cap
declined
from Apr. 2023 (€11.46 Mil) to Apr. 2024 (€2.80 Mil) but then
increased
from Apr. 2024 (€2.80 Mil) to Apr. 2025 (€8.79 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Izotropic's Enterprise Value for Today is €11.96 Mil.
Izotropic (FRA:1R3) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Izotropic Market Cap Related Terms
Izotropic Market Cap Historical Data
* Premium members only.
The historical data trend for Izotropic's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Izotropic's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Izotropic Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Izotropic's Market Cap distribution charts can be found below:
* The bar in red indicates where Izotropic's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Izotropic's Market Cap for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Izotropic (FRA:1R3) has a Market Cap of €10.24 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Izotropic and its competitors. According to the industry distribution chart, Izotropic ranks #169 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 77.5%.
Is Izotropic's Market Cap too high?
Izotropic's current Market Cap is €10.24 Mil. Based on the distribution chart, Izotropic ranks #169 out of 218 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Izotropic has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Izotropic's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Izotropic ranks #169 out of 218 companies for Market Cap. This places Izotropic in the lower half of its industry. The industry median Market Cap is 58.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 58.71, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Izotropic and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 58.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Izotropic's current Market Cap is €10.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Izotropic stock overvalued right now?
Izotropic (FRA:1R3) has a current Market Cap of €10.24 Mil. The current Market Cap is €10.24 Mil. Izotropic's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Izotropic (FRA:1R3), the current Market Cap is €10.24 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
28GF Score
Get the complete analysis for FRA:1R3
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1R3 has been successfully added to your 
